Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

KRYS holding history

Krystal Biotech, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings

Shares (Q2 2026)
251
Value
$93.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of KRYS by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026251$93.3K<0.1%+17+7.3%AddedHolders
Q1 2026234$60.4K<0.1%−79−25.2%ReducedHolders
Q4 2025313$77.2K<0.1%+3+1.0%AddedHolders
Q3 2025310$54.7K<0.1%−194−38.5%ReducedHolders
Q2 2025504$69.3K<0.1%−135−21.1%ReducedHolders
Q1 2025639$115.2K<0.1%−388−37.8%ReducedHolders
Q4 20241,027$160.9K<0.1%+82+8.7%AddedHolders
Q3 2024945$172.0K<0.1%−818−46.4%ReducedHolders
Q2 20241,763$323.8K<0.1%−34−1.9%ReducedHolders
Q1 20241,797$319.7K<0.1%+173+10.7%AddedHolders
Q4 20231,624$201.5K<0.1%+1,435+759.3%AddedHolders
Q3 2023189$21.9K<0.1%00.0%UnchangedHolders
Q2 2023189$22.2K<0.1%+10+5.6%AddedHolders
Q1 2023179$14.3K<0.1%−13−6.8%ReducedHolders
Q4 2022192$15.2K<0.1%−48−20.0%ReducedHolders
Q3 2022240$17.0K<0.1%−166−40.9%ReducedHolders
Q2 2022406$27.0K<0.1%−265−39.5%ReducedHolders
Q1 2022671$45.0K<0.1%−164−19.6%ReducedHolders
Q4 2021835$58.0K<0.1%+725+659.1%AddedHolders
Q3 2021110$6.00K<0.1%+16+17.0%AddedHolders
Q2 202194$6.00K<0.1%−111−54.1%ReducedHolders
Q1 2021205$16.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.